$0.69
-0.02 (-3.44%)
Open$0.71
Previous Close$0.71
Day High$0.72
Day Low$0.68
52W High$7.20
52W Low$0.46
Volume—
Avg Volume347.0K
Market Cap21.13M
P/E Ratio—
EPS$-1.29
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+5,239.6% upside
Current
$0.69
$0.69
Target
$36.71
$36.71
$29.06
$36.71 avg
$43.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.85M | 1.83M | 1.75M |
| Net Income | 558.6K | 478.0K | 437.1K |
| Profit Margin | 30.2% | 26.2% | 25.0% |
| EBITDA | 671.1K | 736.1K | 607.5K |
| Free Cash Flow | 473.4K | 406.9K | 399.5K |
| Rev Growth | +1.8% | +20.8% | +4.5% |
| Debt/Equity | 0.11 | 0.11 | 0.14 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |